Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ebert

Showing results (131-140 of 225) with videos related to

Pageof 23
Sort By:
Plos One|September 23, 2016
Altered Markers of Brain Development in Crohn's Disease with Extraintestinal Manifestations - A Pilot StudyAnne K Thomann, Philipp A Thomann, Robert C Wolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junctionM Moehler, S Kanzler, M Geissler, et al.
International Journal of Colorectal Disease|November 30, 2016
Multiple behavioral factors are associated with occurrence of large, flat colorectal polypsTianzuo Zhan, Felix Hahn, Thomas Hielscher, et al.
BMC Cancer|March 16, 2019
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)Nadja M Meindl-Beinker, Johannes Betge, Tobias Gutting, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 23, 2021
Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma RecurrenceTobias Gutting, Andreas Merkel, David J Fink, et al.
BMC Cancer|July 20, 2018
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)Johannes Betge, Jing Chi-Kern, Nadine Schulte, et al.
Nanotechnology|December 20, 2018
Composition modulation by twinning in InAsSb nanowiresM Schnedler, T Xu, V Portz, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2018
Clinical evaluation of the M-ANNHEIM classification: Development of the M-ANNHEIM-Surgery-Score as a new tool to monitor patients with chronic pancreatitisMichael Hirth, Christel Weiss, Felix Rückert, et al.
Targeted Oncology|April 20, 2026
Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX DatabaseLena Dreikhausen, Alexander Olkus, Michael Dill, et al.
Gastroenterology|April 3, 2012
Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2Ivonne Regel, Lisa Merkl, Teresa Friedrich, et al.
Pageof 23

Showing results (131-140 of 225) with videos related to

Sort By:
Pageof 23
Plos One|September 23, 2016
Altered Markers of Brain Development in Crohn's Disease with Extraintestinal Manifestations - A Pilot StudyAnne K Thomann, Philipp A Thomann, Robert C Wolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junctionM Moehler, S Kanzler, M Geissler, et al.
International Journal of Colorectal Disease|November 30, 2016
Multiple behavioral factors are associated with occurrence of large, flat colorectal polypsTianzuo Zhan, Felix Hahn, Thomas Hielscher, et al.
BMC Cancer|March 16, 2019
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)Nadja M Meindl-Beinker, Johannes Betge, Tobias Gutting, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 23, 2021
Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma RecurrenceTobias Gutting, Andreas Merkel, David J Fink, et al.
BMC Cancer|July 20, 2018
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)Johannes Betge, Jing Chi-Kern, Nadine Schulte, et al.
Nanotechnology|December 20, 2018
Composition modulation by twinning in InAsSb nanowiresM Schnedler, T Xu, V Portz, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2018
Clinical evaluation of the M-ANNHEIM classification: Development of the M-ANNHEIM-Surgery-Score as a new tool to monitor patients with chronic pancreatitisMichael Hirth, Christel Weiss, Felix Rückert, et al.
Targeted Oncology|April 20, 2026
Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX DatabaseLena Dreikhausen, Alexander Olkus, Michael Dill, et al.
Gastroenterology|April 3, 2012
Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2Ivonne Regel, Lisa Merkl, Teresa Friedrich, et al.
Pageof 23